The Investment Management Group at Duncan Williams Asset Management is led by a team with extensive experience in investment management, financial planning, and client service. President David Scully, CFA®, CFP®, has more than 20 years of experience and is active in Memphis civic organizations. Chief Investment Officer Kyle Gowen, CFA®, CFP®, oversees investment strategy and is engaged with the local community. Investment Analyst Jack Eason, CFA®, provides research and supports charitable initiatives. The IMG team is committed to professional standards, client service, and community involvement. No statement is intended as an offer of investment advice or a guarantee of future results.
A pullback in Treasury yields helped U.S. equities snap a three‑day dip, though early strength faded into the close. Healthcare led on upbeat cancer-therapy data, while semiconductors and AI infrastructure remained a drag. Traders also kept one eye on the Fed minutes, tempering risk after the initial rates-driven relief rally.
Key Headlines & Market Movers
Treasury buyback tweak cools yields, rally then pares: The U.S. Treasury signaled it will buy more long‑dated bonds, easing pressure in rates and giving equities an early lift. Benchmark yields slipped on the announcement, loosening the tight financial conditions that had been weighing on risk assets. Into the afternoon, gains moderated as profit‑taking set in and investors acknowledged that the longer‑term rates debate isn’t settled by a single operations tweak.
Healthcare steals the show on late‑stage cancer trial win: Moderna and Merck rallied after reporting that a personalized mRNA therapy reduced melanoma recurrence and spread in a late‑stage study, igniting a broad bid in healthcare. The move provided welcome sector leadership on a day when index gains were otherwise modest. Positive drug data can be idiosyncratic, but the scale of today’s move shifted market tone and diversified leadership beyond mega‑cap tech.
AI complex and chips still heavy, with global tech under strain: Despite relief from rates, chipmakers and AI infrastructure names stayed on the back foot, capping the Nasdaq’s advance. Overseas, weakness in Asia’s tech-heavy markets underscored the fragility of the recent AI run and the sensitivity of high‑duration growth to rate swings. The divergence—defensive healthcare up, cyclical tech mixed—kept breadth uneven.
Focus turns to the Fed minutes for clues on how officials weigh sticky inflation against growth and financial conditions, and whether the buyback-fueled easing in yields has legs. Watch if healthcare leadership broadens and whether semis can stabilize; if rates drift lower but leadership narrows, expect choppier tape until earnings or policy deliver a clearer catalyst.
Ready to take action?
Let's talk about your financial future.
A local Memphis advisor is ready to listen. No pressure, no obligation.